Viking Therapeutics Inc. (VKTX) NASDAQ
$82 (1.34) (-1.61%)
Market Cap: $8.24B
As of 03/28/24 04:00 PM EDT. Market closed.
Viking Therapeutics Inc. (VKTX)
NASDAQ
$82
(1.34) (-1.61%)
Market Cap: $8.24B
As of 03/28/24 04:00 PM EDT. Market closed.
Add to Portfolio
novel therapeutics for metabolic and endocrine ... read more
novel therapeutics for metabolic and endocrine disorders. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$485,000
CEO Compensation (Total)
$1.40M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Brian Lian
CEO Compensation (Base)
$485,000
CEO Compensation (Total)
$1.40M
Address
12340 El Camino Real Ste 250, California, San Diego, 92130-3093.
PRICE CHART FOR VIKING THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$83.56
Previous Close
$83.34
Days Range
$80.50 - $84.70
52 week range
$8.28 - $99.41
Volume
4,331,410
Avg. Volume (30 days)
9,135,884
Market Cap
$8.24B
Dividend Yield
-
P/E
-
Shares Outstanding
100,488,339
Open
$83.56
Previous Close
$83.34
Days Range
$80.50 - $84.70
52 week range
$8.28 - $99.41
Volume
4,331,410
Avg. Volume (30 days)
9,135,884
Market Cap
$8.24B
Dividend Yield
-
P/E
-
Shares Outstanding
100,488,339
FINANCIAL STATEMENTS FOR VIKING THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR VIKING THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Mancini Marianna | Chief Operating Officer | Mar 27, 2024 | Option Exercise | $83.34 | 16,610 | 1,384,277 | 363,565 | Mar 27, 2024, 08:52 PM |
Lian Brian | President & CEO | Mar 27, 2024 | Option Exercise | $83.34 | 153,948 | 12,830,026 | 2,266,453 | Mar 27, 2024, 08:51 PM |
ZANTE GREG | Chief Financial Officer | Mar 27, 2024 | Option Exercise | $83.34 | 16,610 | 1,384,277 | 207,361 | Mar 27, 2024, 08:50 PM |
Lian Brian | President & CEO | Mar 01, 2024 | Option Exercise | $85.22 | 162,815 | 13,875,094 | 2,198,734 | Mar 04, 2024, 07:54 PM |
Mancini Marianna | Chief Operating Officer | Mar 01, 2024 | Option Exercise | $85.22 | 16,958 | 1,445,161 | 348,508 | Mar 04, 2024, 07:52 PM |
ZANTE GREG | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $85.22 | 20,093 | 1,712,325 | 192,304 | Mar 04, 2024, 07:50 PM |
Lian Brian | President & CEO | Feb 09, 2024 | Sale | $29.90 | 45,000 | 1,345,500 | 2,139,882 | Feb 09, 2024, 08:59 PM |
Lian Brian | President & CEO | Feb 08, 2024 | Option Exercise | $3.76 | 189,079 | 711,367 | 2,404,882 | Feb 08, 2024, 07:40 PM |
Lian Brian | President & CEO | Feb 08, 2024 | Sale | $26.87 | 269,079 | 7,230,784 | 2,344,882 | Feb 08, 2024, 07:40 PM |
Rouan Sarah Kathryn | Director | Feb 08, 2024 | Option Exercise | $8.32 | 25,000 | 208,000 | 25,000 | Feb 08, 2024, 07:38 PM |
Rouan Sarah Kathryn | Director | Feb 08, 2024 | Sale | $28.05 | 25,000 | 701,250 | 0 | Feb 08, 2024, 07:38 PM |
Lian Brian | President & CEO | Jan 31, 2024 | Option Exercise | $1.23 | 85,000 | 104,550 | 2,349,882 | Jan 31, 2024, 08:39 PM |
Lian Brian | President & CEO | Jan 31, 2024 | Sale | $24.71 | 85,000 | 2,100,750 | 2,309,882 | Jan 31, 2024, 08:39 PM |
Lian Brian | President & CEO | Jan 30, 2024 | Option Exercise | $1.23 | 35,000 | 43,050 | 2,299,882 | Jan 30, 2024, 09:05 PM |
Lian Brian | President & CEO | Jan 30, 2024 | Sale | $23.95 | 35,000 | 838,250 | 2,264,882 | Jan 30, 2024, 09:05 PM |
Rouan Sarah Kathryn | Director | Jan 19, 2024 | Option Exercise | $8.32 | 30,000 | 249,600 | 30,000 | Jan 19, 2024, 08:35 PM |
Rouan Sarah Kathryn | Director | Jan 19, 2024 | Sale | $23.05 | 30,000 | 691,500 | 0 | Jan 19, 2024, 08:35 PM |
Lian Brian | President & CEO | Jan 03, 2024 | Option Exercise | $17.40 | 214,640 | 3,734,736 | 2,304,434 | Jan 04, 2024, 09:37 PM |
Lian Brian | President & CEO | Jan 04, 2024 | Option Exercise | $18.58 | 39,552 | 734,876 | 2,264,882 | Jan 04, 2024, 09:37 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2024 | Option Exercise | $18.58 | 14,199 | 263,817 | 333,799 | Jan 04, 2024, 09:36 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2024 | Option Exercise | $17.40 | 49,210 | 856,254 | 347,998 | Jan 04, 2024, 09:36 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2024 | Option Exercise | $18.58 | 13,872 | 257,742 | 195,730 | Jan 04, 2024, 09:35 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2024 | Option Exercise | $17.40 | 49,122 | 854,723 | 209,602 | Jan 04, 2024, 09:35 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2024 | Sale | $17.90 | 15,000 | 268,500 | 180,730 | Jan 04, 2024, 09:35 PM |
Rowland Charles A Jr | Director | May 16, 2023 | Option Exercise | $1.08 | 40,000 | 43,200 | 70,000 | May 18, 2023, 06:31 PM |
Rowland Charles A Jr | Director | May 16, 2023 | Sale | $25.00 | 40,000 | 1,000,000 | 30,000 | May 18, 2023, 06:31 PM |
MACARTNEY LAWSON | Director | May 16, 2023 | Option Exercise | $1.19 | 16,000 | 19,040 | 63,965 | May 18, 2023, 06:30 PM |
MACARTNEY LAWSON | Director | May 16, 2023 | Sale | $24.00 | 16,000 | 384,000 | 47,965 | May 18, 2023, 06:30 PM |
Lian Brian | President & CEO | May 01, 2023 | Sale | $22.45 | 45,000 | 1,010,250 | 2,197,963 | May 01, 2023, 07:03 PM |
MACARTNEY LAWSON | Director | Apr 24, 2023 | Option Exercise | $3.33 | 16,000 | 53,280 | 63,965 | Apr 24, 2023, 07:31 PM |
MACARTNEY LAWSON | Director | Apr 24, 2023 | Sale | $22.00 | 16,000 | 352,061 | 47,965 | Apr 24, 2023, 07:31 PM |
Lian Brian | President & CEO | Apr 19, 2023 | Sale | $21.45 | 35,000 | 750,750 | 2,242,963 | Apr 21, 2023, 07:29 PM |
MACARTNEY LAWSON | Director | Apr 17, 2023 | Option Exercise | $8.00 | 20,786 | 166,288 | 68,751 | Apr 18, 2023, 07:10 PM |
MACARTNEY LAWSON | Director | Apr 17, 2023 | Sale | $20.00 | 20,786 | 415,720 | 47,965 | Apr 18, 2023, 07:10 PM |
Lian Brian | President & CEO | Apr 17, 2023 | Option Exercise | $2.15 | 125,000 | 268,750 | 2,432,963 | Apr 18, 2023, 07:09 PM |
Lian Brian | President & CEO | Apr 17, 2023 | Sale | $20.45 | 155,000 | 3,169,765 | 2,277,963 | Apr 18, 2023, 07:09 PM |
Mancini Marianna | Chief Operating Officer | Apr 17, 2023 | Option Exercise | $13.07 | 12,500 | 163,375 | 300,263 | Apr 18, 2023, 07:08 PM |
Mancini Marianna | Chief Operating Officer | Apr 17, 2023 | Sale | $20.00 | 12,500 | 250,000 | 287,763 | Apr 18, 2023, 07:08 PM |
ZANTE GREG | Chief Financial Officer | Apr 17, 2023 | Option Exercise | $13.07 | 7,500 | 98,025 | 156,779 | Apr 18, 2023, 07:07 PM |
ZANTE GREG | Chief Financial Officer | Apr 17, 2023 | Sale | $20.00 | 7,500 | 150,000 | 149,279 | Apr 18, 2023, 07:07 PM |
Lian Brian | President & CEO | Apr 13, 2023 | Option Exercise | $1.88 | 54,336 | 102,152 | 2,387,299 | Apr 13, 2023, 05:14 PM |
Lian Brian | President & CEO | Apr 13, 2023 | Sale | $18.45 | 79,336 | 1,463,749 | 2,307,963 | Apr 13, 2023, 05:14 PM |
ZANTE GREG | Chief Financial Officer | Apr 12, 2023 | Option Exercise | $5.99 | 41,544 | 249,026 | 190,823 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 11, 2023 | Option Exercise | $5.25 | 56,295 | 295,778 | 205,574 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 12, 2023 | Sale | $18.00 | 41,544 | 747,792 | 149,279 | Apr 13, 2023, 05:13 PM |
ZANTE GREG | Chief Financial Officer | Apr 11, 2023 | Sale | $18.00 | 56,295 | 1,013,518 | 149,279 | Apr 13, 2023, 05:13 PM |
Lian Brian | President & CEO | Apr 03, 2023 | Option Exercise | $17.57 | 200,000 | 3,514,000 | 2,332,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 31, 2023 | Option Exercise | $9.49 | 67,970 | 645,035 | 2,322,933 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 30, 2023 | Option Exercise | $2.42 | 135,382 | 327,838 | 2,408,345 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Apr 03, 2023 | Sale | $17.85 | 22,000 | 392,700 | 2,232,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 31, 2023 | Sale | $17.45 | 67,970 | 1,186,077 | 2,254,963 | Apr 03, 2023, 07:26 PM |
Lian Brian | President & CEO | Mar 30, 2023 | Sale | $17.16 | 153,382 | 2,632,516 | 2,320,345 | Apr 03, 2023, 07:26 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $17.57 | 55,166 | 969,267 | 149,279 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Option Exercise | $7.77 | 30,911 | 240,178 | 178,689 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Mar 30, 2023 | Option Exercise | $7.29 | 93,750 | 683,483 | 278,807 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Apr 03, 2023 | Sale | $18.00 | 30,911 | 556,398 | 147,778 | Apr 03, 2023, 07:24 PM |
ZANTE GREG | Chief Financial Officer | Mar 30, 2023 | Sale | $17.00 | 131,029 | 2,227,821 | 147,778 | Apr 03, 2023, 07:24 PM |
Mancini Marianna | Chief Operating Officer | Mar 30, 2023 | Option Exercise | $17.57 | 30,799 | 541,138 | 287,763 | Apr 03, 2023, 07:22 PM |
Mancini Marianna | Chief Operating Officer | Mar 30, 2023 | Option Exercise | $12.56 | 72,200 | 907,151 | 297,995 | Apr 03, 2023, 07:22 PM |
Mancini Marianna | Chief Operating Officer | Mar 29, 2023 | Option Exercise | $9.13 | 15,000 | 136,950 | 303,137 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 28, 2023 | Option Exercise | $2.37 | 167,427 | 397,193 | 484,700 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 29, 2023 | Sale | $16.00 | 41,242 | 659,872 | 261,895 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Mar 28, 2023 | Sale | $15.00 | 196,563 | 2,948,445 | 288,137 | Mar 30, 2023, 09:04 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2023 | Option Exercise | $8.95 | 1,079 | 9,657 | 317,273 | Jan 17, 2023, 07:39 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2023 | Option Exercise | $8.52 | 23,933 | 203,909 | 205,765 | Jan 04, 2023, 06:25 PM |
ZANTE GREG | Chief Financial Officer | Dec 30, 2022 | Option Exercise | $9.40 | 19,697 | 185,152 | 139,031 | Jan 04, 2023, 06:25 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2023 | Option Exercise | $8.42 | 20,708 | 174,361 | 185,057 | Jan 04, 2023, 06:25 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2023 | Option Exercise | $8.42 | 13,994 | 117,829 | 318,352 | Jan 04, 2023, 06:24 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2023 | Option Exercise | $8.52 | 18,854 | 160,636 | 332,346 | Jan 04, 2023, 06:24 PM |
Mancini Marianna | Chief Operating Officer | Dec 30, 2022 | Option Exercise | $9.40 | 12,773 | 120,066 | 260,533 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Dec 30, 2022 | Option Exercise | $9.40 | 66,127 | 621,594 | 2,103,167 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Jan 04, 2023 | Option Exercise | $8.42 | 28,619 | 240,972 | 2,272,963 | Jan 04, 2023, 06:24 PM |
Lian Brian | President & CEO | Jan 03, 2023 | Option Exercise | $8.52 | 68,252 | 581,507 | 2,301,582 | Jan 04, 2023, 06:24 PM |
FOEHR MATTHEW W | Director | May 02, 2022 | Buy | $2.47 | 45,000 | 111,195 | 111,250 | May 03, 2022, 04:12 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2022 | Option Exercise | $4.24 | 827 | 3,506 | 238,695 | Feb 11, 2022, 06:34 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2022 | Option Exercise | $4.62 | 8,835 | 40,818 | 136,304 | Jan 05, 2022, 07:13 PM |
ZANTE GREG | Chief Financial Officer | Jan 03, 2022 | Option Exercise | $4.88 | 3,097 | 15,113 | 91,806 | Jan 05, 2022, 07:13 PM |
Mancini Marianna | Chief Operating Officer | Jan 03, 2022 | Option Exercise | $4.88 | 3,919 | 19,125 | 174,034 | Jan 05, 2022, 07:12 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2022 | Option Exercise | $4.62 | 11,845 | 54,724 | 239,522 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Jan 04, 2022 | Option Exercise | $4.62 | 26,432 | 122,116 | 2,036,686 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Jan 03, 2022 | Option Exercise | $4.88 | 36,319 | 177,237 | 1,889,785 | Jan 05, 2022, 07:12 PM |
Lian Brian | President & CEO | Sep 28, 2021 | Option Exercise | $6.50 | 27,750 | 180,375 | 1,924,807 | Sep 30, 2021, 05:48 PM |
Mancini Marianna | Chief Operating Officer | Sep 28, 2021 | Option Exercise | $6.50 | 2,839 | 18,454 | 177,535 | Sep 30, 2021, 05:45 PM |
ZANTE GREG | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $6.50 | 2,306 | 14,989 | 94,485 | Sep 30, 2021, 05:43 PM |
FOEHR MATTHEW W | Director | Jun 10, 2021 | Buy | $5.69 | 20,000 | 113,800 | 66,250 | Jun 10, 2021, 04:57 PM |
FOEHR MATTHEW W | Director | Mar 22, 2021 | Option Exercise | $1.50 | 20,000 | 30,000 | 46,250 | Mar 25, 2021, 09:30 PM |
ZANTE GREG | Chief Financial Officer | Jan 19, 2021 | Option Exercise | $6.68 | 808 | 5,397 | 89,751 | Jan 19, 2021, 06:25 PM |
Mancini Marianna | Chief Operating Officer | Jan 19, 2021 | Option Exercise | $6.68 | 994 | 6,640 | 169,952 | Jan 19, 2021, 06:23 PM |
Mancini Marianna | Chief Operating Officer | Jan 15, 2021 | Option Exercise | $6.48 | 686 | 4,445 | 170,946 | Jan 19, 2021, 06:23 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2021 | Option Exercise | $6.68 | 1,685 | 11,256 | 116,062 | Jan 19, 2021, 06:21 PM |
Lian Brian | President & CEO | Jan 19, 2021 | Option Exercise | $6.68 | 5,611 | 37,481 | 1,894,181 | Jan 19, 2021, 06:19 PM |
Lian Brian | President & CEO | Jan 04, 2021 | Option Exercise | $5.80 | 16,973 | 98,443 | 1,899,792 | Jan 06, 2021, 04:34 PM |
Lian Brian | President & CEO | Jan 03, 2021 | Option Exercise | $5.63 | 31,545 | 177,598 | 1,712,432 | Jan 06, 2021, 04:34 PM |
ZANTE GREG | Chief Financial Officer | Jan 04, 2021 | Option Exercise | $5.80 | 2,787 | 16,165 | 90,559 | Jan 06, 2021, 04:28 PM |
Mancini Marianna | Chief Operating Officer | Jan 04, 2021 | Option Exercise | $5.80 | 2,773 | 16,083 | 171,632 | Jan 06, 2021, 04:26 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 04, 2021 | Option Exercise | $5.80 | 2,739 | 15,886 | 117,747 | Jan 06, 2021, 12:00 AM |
MORNEAU MICHAEL | VP, Finance and Administration | Sep 15, 2020 | Option Exercise | $6.25 | 1,557 | 9,731 | 97,873 | Sep 16, 2020, 05:21 PM |
Lian Brian | President & CEO | Sep 15, 2020 | Option Exercise | $6.25 | 19,192 | 119,950 | 1,742,363 | Sep 16, 2020, 05:18 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 26, 2020 | Sale | $8.11 | 148,700 | 1,205,660 | 5,819,383 | Aug 28, 2020, 05:11 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 26, 2020 | Sale | $8.11 | 94,488 | 766,109 | 5,819,383 | Aug 27, 2020, 07:06 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Aug 25, 2020 | Sale | $8.02 | 70,000 | 561,575 | 5,968,083 | Aug 27, 2020, 07:06 PM |
FOEHR MATTHEW W | Director | Jun 30, 2020 | Sale | $7.35 | 13,000 | 95,550 | 26,250 | Jun 30, 2020, 05:54 PM |
Lian Brian | President & CEO | Jan 19, 2020 | Option Exercise | $7.18 | 3,195 | 22,940 | 1,704,312 | Jan 21, 2020, 05:39 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2020 | Option Exercise | $7.18 | 2,044 | 14,676 | 92,840 | Jan 21, 2020, 05:35 PM |
Lian Brian | President & CEO | Jan 03, 2020 | Option Exercise | $7.77 | 6,782 | 52,696 | 1,707,507 | Jan 03, 2020, 08:01 PM |
MORNEAU MICHAEL | VP, Finance and Administration | Jan 19, 2019 | Option Exercise | $8.78 | 2,044 | 17,946 | 91,991 | Jan 22, 2019, 07:13 PM |
Lian Brian | President & CEO | Jan 19, 2019 | Option Exercise | $8.78 | 4,333 | 38,044 | 1,560,152 | Jan 22, 2019, 07:13 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Sep 25, 2018 | Sale | $19.15 | 262,881 | 5,034,250 | 6,038,083 | Sep 27, 2018, 09:25 PM |
SINGLETON J MATTHEW | Director | May 31, 2018 | Buy | $9.82 | 9,500 | 93,261 | 9,500 | May 31, 2018, 07:04 PM |
MORNEAU MICHAEL | VP, Finance and Administration | May 31, 2018 | Sale | $9.25 | 21,551 | 199,347 | 94,035 | May 31, 2018, 07:03 PM |
Rowland Charles A Jr | Director | May 29, 2018 | Buy | $5.16 | 30,000 | 154,800 | 30,000 | May 31, 2018, 07:02 PM |
Webster Stephen W | Director | May 29, 2018 | Buy | $5.21 | 8,000 | 41,712 | 8,000 | May 31, 2018, 06:59 PM |
MACARTNEY LAWSON | Director | May 29, 2018 | Buy | $5.22 | 47,965 | 250,329 | 47,965 | May 31, 2018, 06:57 PM |
MORNEAU MICHAEL | VP, Finance and Administration | May 04, 2018 | Option Exercise | $4.22 | 7,616 | 32,140 | 94,035 | May 08, 2018, 08:37 PM |
Lian Brian | President & CEO | May 04, 2018 | Option Exercise | $4.22 | 10,086 | 42,563 | 1,483,012 | May 08, 2018, 08:37 PM |
MORNEAU MICHAEL | Chief Financial Officer | May 04, 2017 | Option Exercise | $1.34 | 8,192 | 10,977 | 80,604 | May 05, 2017, 06:25 PM |
FOEHR MATTHEW W | Director | Nov 15, 2016 | Buy | $1.21 | 13,000 | 15,678 | 39,250 | Nov 15, 2016, 04:34 PM |
Hanley Rochelle | Chief Medical Officer | May 04, 2016 | Option Exercise | $1.31 | 10,595 | 13,879 | 160,836 | May 05, 2016, 05:36 PM |
LIGAND PHARMACEUTICALS INC | 10% Owner | Apr 13, 2016 | Option Exercise | $1.25 | 960,000 | 1,200,000 | 6,300,964 | Apr 15, 2016, 05:19 PM |
FOEHR MATTHEW W | Director | Apr 13, 2016 | Buy | $1.24 | 20,000 | 24,800 | 26,250 | Apr 13, 2016, 06:17 PM |
Lian Brian | President & CEO | May 04, 2015 | Option Exercise | $9.49 | 16,346 | 155,124 | 1,453,098 | May 06, 2015, 08:20 PM |
Dinerman Michael | Chief Operating Officer | May 04, 2015 | Option Exercise | $9.49 | 8,724 | 82,791 | 694,116 | May 06, 2015, 08:19 PM |
MORNEAU MICHAEL | Chief Financial Officer | May 04, 2015 | Option Exercise | $9.49 | 10,404 | 98,734 | 77,404 | May 06, 2015, 07:20 PM |
Hanley Rochelle | Chief Medical Officer | May 04, 2015 | Option Exercise | $9.49 | 7,308 | 69,353 | 168,855 | May 06, 2015, 07:18 PM |
FOEHR MATTHEW W | Director | May 04, 2015 | Buy | $8.00 | 6,250 | 50,000 | 6,250 | May 05, 2015, 01:47 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Mancini Marianna | Chief Operating Officer | 03/27/2024 | 1,384,277 |
Lian Brian | President & CEO | 03/27/2024 | 12,830,026 |
ZANTE GREG | Chief Financial Officer | 03/27/2024 | 1,384,277 |
Lian Brian | President & CEO | 03/01/2024 | 13,875,094 |
Mancini Marianna | Chief Operating Officer | 03/01/2024 | 1,445,161 |
ZANTE GREG | Chief Financial Officer | 03/01/2024 | 1,712,325 |
Lian Brian | President & CEO | 02/09/2024 | 1,345,500 |
Lian Brian | President & CEO | 02/08/2024 | 711,367 |
Lian Brian | President & CEO | 02/08/2024 | 7,230,784 |
Rouan Sarah Kathryn | Director | 02/08/2024 | 208,000 |
Rouan Sarah Kathryn | Director | 02/08/2024 | 701,250 |
Lian Brian | President & CEO | 01/31/2024 | 104,550 |
Lian Brian | President & CEO | 01/31/2024 | 2,100,750 |
Lian Brian | President & CEO | 01/30/2024 | 43,050 |
Lian Brian | President & CEO | 01/30/2024 | 838,250 |
Rouan Sarah Kathryn | Director | 01/19/2024 | 249,600 |
Rouan Sarah Kathryn | Director | 01/19/2024 | 691,500 |
Lian Brian | President & CEO | 01/03/2024 | 3,734,736 |
Lian Brian | President & CEO | 01/04/2024 | 734,876 |
Mancini Marianna | Chief Operating Officer | 01/04/2024 | 263,817 |
Mancini Marianna | Chief Operating Officer | 01/03/2024 | 856,254 |
ZANTE GREG | Chief Financial Officer | 01/04/2024 | 257,742 |
ZANTE GREG | Chief Financial Officer | 01/03/2024 | 854,723 |
ZANTE GREG | Chief Financial Officer | 01/04/2024 | 268,500 |
Rowland Charles A Jr | Director | 05/16/2023 | 43,200 |
Rowland Charles A Jr | Director | 05/16/2023 | 1,000,000 |
MACARTNEY LAWSON | Director | 05/16/2023 | 19,040 |
MACARTNEY LAWSON | Director | 05/16/2023 | 384,000 |
Lian Brian | President & CEO | 05/01/2023 | 1,010,250 |
MACARTNEY LAWSON | Director | 04/24/2023 | 53,280 |
MACARTNEY LAWSON | Director | 04/24/2023 | 352,061 |
Lian Brian | President & CEO | 04/19/2023 | 750,750 |
MACARTNEY LAWSON | Director | 04/17/2023 | 166,288 |
MACARTNEY LAWSON | Director | 04/17/2023 | 415,720 |
Lian Brian | President & CEO | 04/17/2023 | 268,750 |
Lian Brian | President & CEO | 04/17/2023 | 3,169,765 |
Mancini Marianna | Chief Operating Officer | 04/17/2023 | 163,375 |
Mancini Marianna | Chief Operating Officer | 04/17/2023 | 250,000 |
ZANTE GREG | Chief Financial Officer | 04/17/2023 | 98,025 |
ZANTE GREG | Chief Financial Officer | 04/17/2023 | 150,000 |
Lian Brian | President & CEO | 04/13/2023 | 102,152 |
Lian Brian | President & CEO | 04/13/2023 | 1,463,749 |
ZANTE GREG | Chief Financial Officer | 04/12/2023 | 249,026 |
ZANTE GREG | Chief Financial Officer | 04/11/2023 | 295,778 |
ZANTE GREG | Chief Financial Officer | 04/12/2023 | 747,792 |
ZANTE GREG | Chief Financial Officer | 04/11/2023 | 1,013,518 |
Lian Brian | President & CEO | 04/03/2023 | 3,514,000 |
Lian Brian | President & CEO | 03/31/2023 | 645,035 |
Lian Brian | President & CEO | 03/30/2023 | 327,838 |
Lian Brian | President & CEO | 04/03/2023 | 392,700 |
Lian Brian | President & CEO | 03/31/2023 | 1,186,077 |
Lian Brian | President & CEO | 03/30/2023 | 2,632,516 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 969,267 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 240,178 |
ZANTE GREG | Chief Financial Officer | 03/30/2023 | 683,483 |
ZANTE GREG | Chief Financial Officer | 04/03/2023 | 556,398 |
ZANTE GREG | Chief Financial Officer | 03/30/2023 | 2,227,821 |
Mancini Marianna | Chief Operating Officer | 03/30/2023 | 541,138 |
Mancini Marianna | Chief Operating Officer | 03/30/2023 | 907,151 |
Mancini Marianna | Chief Operating Officer | 03/29/2023 | 136,950 |
Mancini Marianna | Chief Operating Officer | 03/28/2023 | 397,193 |
Mancini Marianna | Chief Operating Officer | 03/29/2023 | 659,872 |
Mancini Marianna | Chief Operating Officer | 03/28/2023 | 2,948,445 |
Mancini Marianna | Chief Operating Officer | 01/15/2023 | 9,657 |
ZANTE GREG | Chief Financial Officer | 01/03/2023 | 203,909 |
ZANTE GREG | Chief Financial Officer | 12/30/2022 | 185,152 |
ZANTE GREG | Chief Financial Officer | 01/04/2023 | 174,361 |
Mancini Marianna | Chief Operating Officer | 01/04/2023 | 117,829 |
Mancini Marianna | Chief Operating Officer | 01/03/2023 | 160,636 |
Mancini Marianna | Chief Operating Officer | 12/30/2022 | 120,066 |
Lian Brian | President & CEO | 12/30/2022 | 621,594 |
Lian Brian | President & CEO | 01/04/2023 | 240,972 |
Lian Brian | President & CEO | 01/03/2023 | 581,507 |
FOEHR MATTHEW W | Director | 05/02/2022 | 111,195 |
Mancini Marianna | Chief Operating Officer | 01/15/2022 | 3,506 |
ZANTE GREG | Chief Financial Officer | 01/04/2022 | 40,818 |
ZANTE GREG | Chief Financial Officer | 01/03/2022 | 15,113 |
Mancini Marianna | Chief Operating Officer | 01/03/2022 | 19,125 |
Mancini Marianna | Chief Operating Officer | 01/04/2022 | 54,724 |
Lian Brian | President & CEO | 01/04/2022 | 122,116 |
Lian Brian | President & CEO | 01/03/2022 | 177,237 |
Lian Brian | President & CEO | 09/28/2021 | 180,375 |
Mancini Marianna | Chief Operating Officer | 09/28/2021 | 18,454 |
ZANTE GREG | Chief Financial Officer | 09/28/2021 | 14,989 |
FOEHR MATTHEW W | Director | 06/10/2021 | 113,800 |
FOEHR MATTHEW W | Director | 03/22/2021 | 30,000 |
ZANTE GREG | Chief Financial Officer | 01/19/2021 | 5,397 |
Mancini Marianna | Chief Operating Officer | 01/19/2021 | 6,640 |
Mancini Marianna | Chief Operating Officer | 01/15/2021 | 4,445 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2021 | 11,256 |
Lian Brian | President & CEO | 01/19/2021 | 37,481 |
Lian Brian | President & CEO | 01/04/2021 | 98,443 |
Lian Brian | President & CEO | 01/03/2021 | 177,598 |
ZANTE GREG | Chief Financial Officer | 01/04/2021 | 16,165 |
Mancini Marianna | Chief Operating Officer | 01/04/2021 | 16,083 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/04/2021 | 15,886 |
MORNEAU MICHAEL | VP, Finance and Administration | 09/15/2020 | 9,731 |
Lian Brian | President & CEO | 09/15/2020 | 119,950 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/26/2020 | 1,205,660 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/26/2020 | 766,109 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 08/25/2020 | 561,575 |
FOEHR MATTHEW W | Director | 06/30/2020 | 95,550 |
Lian Brian | President & CEO | 01/19/2020 | 22,940 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2020 | 14,676 |
Lian Brian | President & CEO | 01/03/2020 | 52,696 |
MORNEAU MICHAEL | VP, Finance and Administration | 01/19/2019 | 17,946 |
Lian Brian | President & CEO | 01/19/2019 | 38,044 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 09/25/2018 | 5,034,250 |
SINGLETON J MATTHEW | Director | 05/31/2018 | 93,261 |
MORNEAU MICHAEL | VP, Finance and Administration | 05/31/2018 | 199,347 |
Rowland Charles A Jr | Director | 05/29/2018 | 154,800 |
Webster Stephen W | Director | 05/29/2018 | 41,712 |
MACARTNEY LAWSON | Director | 05/29/2018 | 250,329 |
MORNEAU MICHAEL | VP, Finance and Administration | 05/04/2018 | 32,140 |
Lian Brian | President & CEO | 05/04/2018 | 42,563 |
MORNEAU MICHAEL | Chief Financial Officer | 05/04/2017 | 10,977 |
FOEHR MATTHEW W | Director | 11/15/2016 | 15,678 |
Hanley Rochelle | Chief Medical Officer | 05/04/2016 | 13,879 |
LIGAND PHARMACEUTICALS INC | 10% Owner | 04/13/2016 | 1,200,000 |
FOEHR MATTHEW W | Director | 04/13/2016 | 24,800 |
Lian Brian | President & CEO | 05/04/2015 | 155,124 |
Dinerman Michael | Chief Operating Officer | 05/04/2015 | 82,791 |
MORNEAU MICHAEL | Chief Financial Officer | 05/04/2015 | 98,734 |
Hanley Rochelle | Chief Medical Officer | 05/04/2015 | 69,353 |
FOEHR MATTHEW W | Director | 05/04/2015 | 50,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VIKING THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 7,605,867 | 0.00361% | 6.66% | Other |
VIKING GLOBAL INVESTORS LP | 5,145,112 | 0.35% | 12.5% | Growth At A Reasonable Price |
BALYASNY ASSET MANAGEMENT L.P. | 2,243,523 | 0.08% | 5.73% | Event Driven |
GEODE CAPITAL MANAGEMENT, LLC | 2,128,343 | 0.00414% | 5.01% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,279,000 | 0.44% | No change | Other |
BALYASNY ASSET MANAGEMENT L.P. | 125,000 (Call) | 0.00437% | -87.98% | Event Driven |
BAMCO INC /NY/ | 310,067 | 0.02% | New | Growth At A Reasonable Price |
D. E. SHAW & CO., INC. | 115,635 | 0.00188% | 34.49% | Other |
ALPS ADVISORS INC | 66,377 | 0.00971% | -10.06% | Other |
UBS OCONNOR LLC | 22,141 | 0.03% | -61.76% | Value |
AQR CAPITAL MANAGEMENT LLC | 47,459 | 0.00166% | -14.74% | Other |
ROYCE & ASSOCIATES LP | 28,037 | 0.00482% | New | Value |
CHANGE IN SHARES OUTSTANDING FOR VIKING THERAPEUTICS INC
STOCK BUYBACKS FOR VIKING THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.10%
1Q
06/30/2023
0.94%
2Q
03/31/2023
27.56%
3Q
12/31/2022
30.50%
4Q
09/30/2022
30.64%
5Q
06/30/2022
30.07%
6Q
03/31/2022
29.11%
7Q
12/31/2021
28.02%
8Q
09/30/2021
28.12%
9Q
06/30/2021
28.30%
10Q
03/31/2021
33.65%
11Q
12/31/2020
37.10%
12Q
09/30/2020
37.58%
13Q
06/30/2020
37.88%
14Q
03/31/2020
38.13%
15Q
12/31/2019
38.59%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VIKING THERAPEUTICS INC
LOADING...